A Study of Cardiac Safety in Patients With HER2 Positive Early Breast Cancer Treated With Herceptin
Status:
Completed
Trial end date:
2016-05-31
Target enrollment:
Participant gender:
Summary
This is a single cohort observational safety study. All patients will be treated and
monitored according to the local clinical practice. No additional procedures/patient visits
in comparison with the usual clinical practice are planned for the study. Data will be
collected from centre's medical records for up to 5 years or death.